CoChat

The consequences of drug misuse on post-marketing surveillance

Open access
Schifano, Fabrizio, Papanti, Gabriele Duccio, Orsolini, Laura, Corkery, John Martin · 2016 · Expert Review of Clinical Pharmacology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Over the past decade, the ‘traditional’ drug scenario has shown significant changes because of the emergence of a range of molecules, e.g. the novel psychoactive substances (NPS), which are either ...

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17512433.2016.1178571

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 41 · Cited by 21

Research works printed but not linked: 5

  1. World Health Organization (WHO). 34th meeting of the WHO Expert Committee on Drug Dependence (ECDD); 2006 Mar 28-31; Geneva, Switzerland.
  2. Sarker A, Ginn R, Nikfarjam A, et al. Utilizing social media data for pharmacovigilance: A review. J Biomed Inform. 2015;54:202-212. · DOI · Paper page
  3. Bogart GT, Ott CA. Abuse of second-generation antipsychotics: what prescribers need to know. Curr Psychiatr. 2011;10(5). [cited 2016 Mar 2]. Available from: http://www.currentpsychiatry.com/ index.php?id=22661&tx_ttnews[tt_news]=176014
  4. Schifano F, D'Offizi S, Piccione M, et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom. 2011;80(2):118-122. · DOI · Paper page
  5. Canadian Agency for Drugs and Technologies in Health (CADTH). Abuse and misuse potential of pregabalin: a review of the clinical evidence; Context and policy issues; 2012 [cited 2016 Mar 7]. Available from: http://dpic.org/sites/default/files/PregabalinAbuse_ CADTH_24Apr2012.pdf

Metadata

Authors
Schifano, F., Papanti, G. D., Orsolini, L., & Corkery, J. M.
Affiliations
University of Hertfordshire (GB)
Corresponding author
Schifano, Fabrizio
Venue
Expert Review of Clinical Pharmacology
Published
2016-04-25
Volume
9
Issue
7
Pages
867-871
ISSN
  • 1751-2433 (ISSN-L)
  • 1751-2441
OpenAlex
W2341524139
Cited by
21
References
41
Citations by year
2025: 2 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 3
Type
journal article
Language
en
Open access
Locations
  • Expert Review of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
Funders
  • European Commission (Drug Prevention and Information Programme 2014–16;)
  • EU Commission (JUST/2013/ISEC/DRUGS/AG/6429) Project EPS/NPS (Enh)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
Keywords
drug abuse, post-marketing surveillance, new psychoactive substances, drug safety, adverse drug reactions, drug regulation
MeSH terms
Humans, Product Surveillance, Postmarketing, Psychotropic Drugs, Substance-Related Disorders, Prescription Drug Misuse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The consequences of drug misuse on post-marketing surveillance. https://app.cochat.ai/papers/10.1080/17512433.2016.1178571
The paper
Schifano, F., Papanti, G. D., Orsolini, L., & Corkery, J. M. (2016). The consequences of drug misuse on post-marketing surveillance. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2016.1178571

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.